WM
Windgap Medical, Inc.
SEC filingPharmaceuticals · Watertown, MA
Amount raised$12.7Msold at filing
Total offering$17.3M$4.6M still open
Investors in the raise13count reported to the SEC
FiledJan 26, 2026first sale Nov 6, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Max Reading MeehanExecutive Officer
Richard RussellDirector
Brent Reading BuchineDirector
Timothy Reading KrochukDirector
Aaron Reading MannExecutive Officer, Director
Jason Reading DurkinExecutive Officer
John Reading CadiganExecutive Officer
Anthony Reading WatsonExecutive Officer
John Reading WilsonDirector
Executive officers, directors and promoters as listed on the Form D.